• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VE-白蛋白核壳纳米粒用于紫杉醇递药治疗多药耐药乳腺癌。

VE-Albumin Core-Shell Nanoparticles for Paclitaxel Delivery to Treat MDR Breast Cancer.

机构信息

School of Pharmacy, Nantong University, 19 Qixiu Road, Nantong 226001, Jiangsu, China.

School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, Liaoning, China.

出版信息

Molecules. 2018 Oct 25;23(11):2760. doi: 10.3390/molecules23112760.

DOI:10.3390/molecules23112760
PMID:30366367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6278303/
Abstract

Multi-drug resistance (MDR) presents a serious problem in cancer chemotherapy. In this study, Vitamin E (VE)-Albumin core-shell nanoparticles were developed for paclitaxel (PTX) delivery to improve the chemotherapy efficacy in an MDR breast cancer model. The PTX-loaded VE-Albumin core-shell nanoparticles (PTX-VE NPs) had small particle sizes (about 100 nm), high drug entrapment efficiency (95.7%) and loading capacity (12.5%), and showed sustained release profiles, in vitro. Docking studies indicated that the hydrophobic interaction and hydrogen bonds play a significant role in the formation of the PTX-VE NPs. The results of confocal laser scanning microscopy analysis demonstrated that the cell uptake of PTX was significantly increased by the PTX-VE NPs, compared with the NPs without VE (PTX NPs). The PTX-VE NPs also exhibited stronger cytotoxicity, compared with PTX NPs with an increased accumulation of PTX in the MCF-7/ADR cells. Importantly, the PTX-VE NPs showed a higher anti-cancer efficacy in MCF-7/ADR tumor xenograft model than the PTX NPs and the PTX solutions. Overall, the VE-Albumin core-shell nanoparticles could be a promising nanocarrier for PTX delivery to improve the chemotherapeutic efficacy of MDR cancer.

摘要

多药耐药性(MDR)是癌症化疗中的一个严重问题。在本研究中,开发了维生素 E(VE)-白蛋白核壳纳米粒用于紫杉醇(PTX)递送,以提高 MDR 乳腺癌模型中的化疗疗效。载紫杉醇的 VE-白蛋白核壳纳米粒(PTX-VE NPs)具有较小的粒径(约 100nm)、高药物包封效率(95.7%)和载药能力(12.5%),并表现出体外持续释放的特性。对接研究表明,疏水性相互作用和氢键在 PTX-VE NPs 的形成中起着重要作用。共聚焦激光扫描显微镜分析的结果表明,与不含 VE 的 NPs(PTX NPs)相比,PTX-VE NPs 显著增加了 PTX 的细胞摄取。PTX-VE NPs 还表现出更强的细胞毒性,与在 MCF-7/ADR 细胞中增加 PTX 积累的 PTX NPs 相比。重要的是,PTX-VE NPs 在 MCF-7/ADR 肿瘤异种移植模型中的抗癌疗效高于 PTX NPs 和 PTX 溶液。总体而言,VE-白蛋白核壳纳米粒可以作为一种有前途的 PTX 递送纳米载体,以提高 MDR 癌症的化疗疗效。

相似文献

1
VE-Albumin Core-Shell Nanoparticles for Paclitaxel Delivery to Treat MDR Breast Cancer.VE-白蛋白核壳纳米粒用于紫杉醇递药治疗多药耐药乳腺癌。
Molecules. 2018 Oct 25;23(11):2760. doi: 10.3390/molecules23112760.
2
Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.叶酸修饰纳米红细胞共载紫杉醇和曲昔匹特克服乳腺癌多药耐药性
Mol Pharm. 2020 Apr 6;17(4):1114-1126. doi: 10.1021/acs.molpharmaceut.9b01148. Epub 2020 Mar 23.
3
TPGS and chondroitin sulfate dual-modified lipid-albumin nanosystem for targeted delivery of chemotherapeutic agent against multidrug-resistant cancer.用于靶向递送化疗药物以对抗多药耐药癌症的TPGS与硫酸软骨素双重修饰的脂质-白蛋白纳米系统
Int J Biol Macromol. 2021 Jul 31;183:1270-1282. doi: 10.1016/j.ijbiomac.2021.05.070. Epub 2021 May 15.
4
Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.重构高密度脂蛋白介导的HZ08和紫杉醇靶向共递送增强了紫杉醇对多药耐药MCF-7乳腺癌细胞的疗效。
Eur J Pharm Sci. 2016 Sep 20;92:11-21. doi: 10.1016/j.ejps.2016.06.017. Epub 2016 Jun 23.
5
Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.基于二硫键连接的聚乙二醇-药物偶联物的新型载游离紫杉醇氧化还原响应性纳米颗粒用于细胞内药物递送:合成、表征及体内外抗肿瘤活性
Mol Pharm. 2014 Oct 6;11(10):3656-70. doi: 10.1021/mp500399j. Epub 2014 Sep 24.
6
Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation.载药白蛋白纳米粒共载紫杉醇和白藜芦醇:体内外评价及结合特性研究。
Int J Biol Macromol. 2020 Jun 15;153:873-882. doi: 10.1016/j.ijbiomac.2020.03.060. Epub 2020 Mar 10.
7
Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.维生素 E-聚(甲基二甘醇谷氨酸盐)作为一种生物相容性和功能性表面活性剂,用于简便制备主动靶向的 PLGA 纳米粒子。
Biomacromolecules. 2016 Jul 11;17(7):2367-74. doi: 10.1021/acs.biomac.6b00380. Epub 2016 Jun 28.
8
Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice.具有 pH 响应性和可聚乙二醇化特性的智能聚合物纳米粒子(二):紫杉醇和 VEGF siRNA 的共递送用于协同治疗小鼠乳腺癌。
Int J Nanomedicine. 2021 Aug 13;16:5479-5494. doi: 10.2147/IJN.S313339. eCollection 2021.
9
Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer.在单一纳米乳剂中联合递送疏水和亲水抗癌药物以治疗癌症中的多药耐药性。
Mol Pharm. 2014 Aug 4;11(8):2623-30. doi: 10.1021/mp400778r. Epub 2014 Apr 21.
10
Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.紫杉醇载 PC L-TPGS 纳米粒:与 Abraxane®的体外和体内性能比较。
Colloids Surf B Biointerfaces. 2014 Jan 1;113:43-50. doi: 10.1016/j.colsurfb.2013.07.036. Epub 2013 Sep 5.

引用本文的文献

1
Use of Albumin for Drug Delivery as a Diagnostic and Therapeutic Tool.白蛋白作为药物递送载体用于诊断和治疗的研究进展。
Curr Pharm Biotechnol. 2024;25(6):676-693. doi: 10.2174/1389201024666230807161200.
2
Novel Development of Nanoparticles-A Promising Direction for Precise Tumor Management.纳米颗粒的新进展——精确肿瘤管理的一个有前景的方向。
Pharmaceutics. 2022 Dec 21;15(1):24. doi: 10.3390/pharmaceutics15010024.
3
Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance.基于白蛋白的纳米颗粒:一种克服癌症耐药性的有前景的策略。

本文引用的文献

1
Overcoming Multidrug Resistance through the Synergistic Effects of Hierarchical pH-Sensitive, ROS-Generating Nanoreactors.通过分级pH敏感、产生活性氧的纳米反应器的协同效应克服多药耐药性
ACS Biomater Sci Eng. 2017 Oct 9;3(10):2431-2442. doi: 10.1021/acsbiomaterials.7b00569. Epub 2017 Sep 22.
2
Overcoming multidrug resistance through co-delivery of ROS-generating nano-machinery in cancer therapeutics.通过在癌症治疗中共同递送产生活性氧的纳米机器克服多药耐药性。
J Mater Chem B. 2017 Feb 21;5(7):1507-1517. doi: 10.1039/c6tb03146c. Epub 2017 Feb 1.
3
Overcoming multidrug resistance through inhalable siRNA nanoparticles-decorated porous microparticles based on supercritical fluid technology.
Cancer Drug Resist. 2020 Nov 3;3(4):930-946. doi: 10.20517/cdr.2020.68. eCollection 2020.
4
Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue.转移性乳腺癌的耐药性:肿瘤靶向纳米医学的救援。
Int J Mol Sci. 2021 Apr 28;22(9):4673. doi: 10.3390/ijms22094673.
5
Special Issue: "Smart and Functional Polymers".特刊:“智能与功能高分子”
Molecules. 2019 Aug 16;24(16):2976. doi: 10.3390/molecules24162976.
6
Cell membrane camouflaged nanoparticles: a new biomimetic platform for cancer photothermal therapy.细胞膜伪装纳米颗粒:一种用于癌症光热治疗的新型仿生平台。
Int J Nanomedicine. 2019 Jun 17;14:4431-4448. doi: 10.2147/IJN.S200284. eCollection 2019.
基于超临界流体技术的吸入型 siRNA 纳米粒修饰多孔微球克服多药耐药性。
Int J Nanomedicine. 2018 Aug 15;13:4685-4698. doi: 10.2147/IJN.S169399. eCollection 2018.
4
Solution-enhanced dispersion by supercritical fluids: an ecofriendly nanonization approach for processing biomaterials and pharmaceutical compounds.超临界流体增强的溶液分散法:一种用于加工生物材料和药物化合物的环保纳米化方法。
Int J Nanomedicine. 2018 Jul 23;13:4227-4245. doi: 10.2147/IJN.S166124. eCollection 2018.
5
Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells.叶酸偶联牛血清白蛋白:一种高效智能的肿瘤靶向生物大分子,用于抑制叶酸受体阳性癌细胞。
Int J Biol Macromol. 2018 Oct 1;117:1125-1132. doi: 10.1016/j.ijbiomac.2018.06.026. Epub 2018 Jun 6.
6
Leveraging Engineering of Indocyanine Green-Encapsulated Polymeric Nanocomposites for Biomedical Applications.利用吲哚菁绿封装的聚合物纳米复合材料工程用于生物医学应用。
Nanomaterials (Basel). 2018 May 24;8(6):360. doi: 10.3390/nano8060360.
7
HSA-based multi-target combination therapy: regulating drugs' release from HSA and overcoming single drug resistance in a breast cancer model.基于人血清白蛋白的多靶点联合治疗:调控药物从人血清白蛋白中的释放并克服乳腺癌模型中的单药耐药性。
Drug Deliv. 2018 Nov;25(1):321-329. doi: 10.1080/10717544.2018.1428245.
8
Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy.载抗癌药物的共递纳米粒以提高化疗疗效。
Drug Deliv. 2017 Nov;24(1):1909-1926. doi: 10.1080/10717544.2017.1410256.
9
Co-delivery strategies to overcome multidrug resistance in ovarian cancer.克服卵巢癌多药耐药的共递送策略。
Int J Pharm. 2017 Nov 25;533(1):111-124. doi: 10.1016/j.ijpharm.2017.09.060. Epub 2017 Sep 22.
10
Polyester-Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel.聚酯-固体脂质混合纳米粒改善了在胃肠道中的稳定性,促进了拉罗他赛的口服递送。
Mol Pharm. 2017 Nov 6;14(11):3750-3761. doi: 10.1021/acs.molpharmaceut.7b00503. Epub 2017 Oct 4.